Arthritis Market Research Reports & Industry Analysis
Rheumatoid arthritis (RA) is a systemic inflammatory disease. In the United States, approximately a single percent of the population is affected. Women are two to three times more likely to develop rheumatoid arthritis than men, with peak incidence between the fourth and sixth decades. Gender difference disappears in older age. Rheumatoid arthritis affects all races, and its prevalence is not affected by climate. Eighty percent of rheumatoid arthritis patients test rheumatoid factor (RF) positive.
Arthritis Industry Research & Market Reports
-
Medical Marijuana Market by Route of Administration (Inhalation, Oral, Topical), Application (Anorexia, Arthritis, Migraine), Distribution Channel - Global Forecast 2024-2030
... to reach USD 15.66 billion in 2024, at a CAGR 9.07% to reach USD 26.16 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Medical Marijuana Market. It offers ... Read More
-
Anti-Inflammatory Therapeutics Market by Drug Class (Anti-inflammatory Biologics, Corticosteroids, Non-steroidal Anti-inflammatory Drugs (NSAIDs)), Indication (Anti-inflammatory Bowel Disease, Arthritis, Multiple Sclerosis), Application - Global Forecast
... billion in 2023 and expected to reach USD 103.85 billion in 2024, at a CAGR 4.93% to reach USD 142.21 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Gout Therapeutics Market by Drug Class (Colchicine, Corticosteroids, NSAIDs), Treatment (Uricosuria Medication, Xanthine Oxidase Inhibitor), Route of Administration, Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 3.05 billion in 2024, at a CAGR 10.95% to reach USD 5.70 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Gout Therapeutics ... Read More
-
Osteoarthritis Therapeutics Market by Anatomy (Hand Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis), Drug Type (Analgesics, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs), Route of Administration, Purchasing Pattern, Distribution Channel
... estimated at USD 7.90 billion in 2023 and expected to reach USD 8.69 billion in 2024, at a CAGR 10.39% to reach USD 15.78 billion by 2030. Global Osteoarthritis Therapeutics Market FPNV Positioning Matrix The ... Read More
-
Non-opioid Pain Patches Market by Patch Type (Capsaicin Patches, Diclofenac Patches, Ketoprofen Patches), Indication (Arthritis, Back Pain, Fibromyalgia), Distribution - Global Forecast 2024-2030
... in 2023 and expected to reach USD 790.97 million in 2024, at a CAGR 12.88% to reach USD 1,637.77 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Non-opioid ... Read More
-
Osteoarthritis Pain Drug Market by Drug Class (Corticosteriods, NSAIDs, Viscosupplementation), Route of Administration (Oral, Parenteral, Topical), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 8.54 billion in 2024, at a CAGR 6.47% to reach USD 12.47 billion by 2030. Global Osteoarthritis Pain Drug Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Tofacitinib Global Market Opportunities And Strategies To 2032 Including: 1) By Drug Class: Antirheumatic; Janus kinase inhibitor; Immunosuppressant 2) By Dosage Strength: 5mg; 10mg; 11mg; 22mg 3) By Indication: Ulcerative Colitis; Rheumatoid Arthritis; Psoriasis 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy Covering: Pfizer Inc.; Beacon Pharmaceuticals PLC; Pharmascience Inc.; Qilu Pharmaceutical Co., Ltd; Delta Pharma Limited
... Pharmacy; Retail Pharmacy; Online PharmacyCovering: Pfizer Inc.; Beacon Pharmaceuticals PLC; Pharmascience Inc.; Qilu Pharmaceutical Co., Ltd; Delta Pharma Limited Tofacitinib Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; ... Read More
-
Gout - Opportunity Assessment and Forecast
... gout in the 7MM is mostly limited to NSAIDs, corticosteroids, and ULTs with challenging safety profiles, such as allopurinol. There are several unmet needs in this space, including the need for improved physician and patient ... Read More
-
Global Osteoarthritis Analgesics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. Osteoarthritis is an inflammatory disease, and pain is closely related to inflammation. Analgesic drugs for ... Read More
-
Global Osteoarthritis Analgesics Supply, Demand and Key Producers, 2023-2029
... (2023-2029). Osteoarthritis is an inflammatory disease, and pain is closely related to inflammation. Analgesic drugs for osteoarthritis are mainly divided into two categories: over-the-counter drugs and prescription drugs. There are three main types: injection, oral ... Read More
-
Enzyme Inhibitor Global Market Report 2024
... Gastrointestinal Disorders; Arthritis; Inflammatory Diseases3) By Application: Chemotherapy; Antibiotics; Pesticides; Cardiovascular Treatments4) By End User: Pharmaceutical; Biotechnology; Food and BeverageCovering: Abbott Laboratories; Amgen Inc.; AstraZeneca plc; Bayer AG; F. Hoffmann-La Roche AG Enzyme Inhibitor Global ... Read More
-
Psoriatic Arthritis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 15.9 Billion by 2028, exhibiting a growth rate (CAGR) of 10.57% during 2022-2028. Psoriatic arthritis is an autoimmune disorder wherein the immune system attacks the joints and causes inflammation. Its treatment options vary ... Read More
-
Gout Market Research Report Forecast till 2030
... a year old, have a high measure of uric corrosive in their blood. As per studies, its commonness and frequency have expanded over the most recent couple of many years. The rising commonness of gout ... Read More
-
Gout Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Non-steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Colchicine, Urate Lowering Agents); By Disease Condition; By Region; Segment Forecast, 2023 - 2032
... market size is expected to reach USD 6.04 billion by 2032, according to a new study by Polaris Market Research. The report “Gout Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Non-steroidal ... Read More
-
US Axial Spondyloarthritis Market outlook to 2028
... causing pain and inflammation in the spine. There are two types of Axial Spondyloarthritis, i.e., Ankylosing Spondylitis and Non-radiographic Spondyloarthritis. According to Ken Research, this market is anticipated to grow at a CAGR of 9.5% ... Read More
-
Orthopedic Regenerative Medicine Market, By Type (Stem Cell, Biomaterial and Tissue Engineering), By Application (Osteoarticular Diseases, Rheumatoid Arthritis, Ligament Injuries, Burisitis, Osteoporosis and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
... and Africa) Orthopedic Regenerative Medicine Market, By Type (Stem Cell, Biomaterial and Tissue Engineering), By Application (Osteoarticular Diseases, Rheumatoid Arthritis, Ligament Injuries, Burisitis, Osteoporosis and Others), By Region (North America, Latin America, Europe, Asia Pacific, ... Read More
-
United States Autoimmune Disease Diagnostics Market By Component (Instruments, Reagents, Consumables), By Test Type (Routine Laboratory Tests, Inflammatory Markers, Antibodies & Immunologic Tests, Others), By Disease Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics) By Systemic Autoimmune Diseases (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others), By Localized Autoimmune Diseases (Multiple Sclerosis, Type 1 Diabetes, Hashimoto’s Thyroiditis, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F
... By Systemic Autoimmune Diseases (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Others), By Localized Autoimmune Diseases (Multiple Sclerosis, Type 1 Diabetes, Hashimoto’s Thyroiditis, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, ... Read More
-
Stem Cell Therapy for Osteoarthritis Industry Research Report 2023
... readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy for Osteoarthritis. The Stem Cell Therapy for Osteoarthritis market size, ... Read More
-
Rheumatoid Arthritis Drugs Market, Size, Share, Global Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... Research. Rheumatoid Arthritis (RA) is an autoimmune condition characterized by inflammation and joint pain. It occurs when the immune system malfunctions and targets the synovium, the lining of the joints. Generally, RA affects symmetrical joints ... Read More
-
Asia Gout Disease Treatment Market
... By Country (China, India, Japan, South Korea, Thailand, Indonesia, Singapore, Vietnam, and Rest of Asian Countries) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Gout is a chronic disease characterized by pain and ... Read More
-
Global Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast to 2030
... by 2030. Autoimmune diseases refer to a body’s abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. Autoimmune diseases can be divided into ... Read More
-
Psoriatic Arthritis Treatment Market by Drug Type (NSAIDs, DMARDs, Biologics, and Others), Type (Prescription, and OTC), and Route of Administration (Topical, Oral, and Injectable): Global Opportunity Analysis and Industry Forecast, 2019-2026 UPDATE AVAILABLE ON-DEMAND Forecast up to 2027
... up to 2027 The psoriatic arthritis treatment market refers to the market for products and therapies used in the management and treatment of psoriatic arthritis (PsA). PsA is a chronic inflammatory arthritis that affects individuals ... Read More
-
Still’s Disease- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Still’s ... Read More
-
Global Autoinjectors Market (4th Edition), 2021-2035 Distribution by Type of Autoinjector (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Therapeutic Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts
... Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts According to the National Health Interview Survey (NHIS), nearly 52% of the adult ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
Research Assistance
